Chinese hackers monitor data of two Indian companies making Covid-19 vaccine

Chinese hackers have tried to steal the data of two Indian companies making Covid-19 Vaccine. A report claims that hackers have tried to break into the data of Bharat Biotech and Serum Institute of India. The APT10 group, which tried hacking, is named Stone Panda and was allegedly intended to break the supply chain of these two companies and steal the Intellectual property. In 2018, in a report released by the US Department of Justice, the group was described as an ally of China’s Ministry of State Security.

News agency Reuters reports that an attempt has been made to break into the much-needed data of Bharat Biotech and Serum Institute, the two major vaccine companies in India. The Chinese hacking group that tried to accomplish this was APT10, better known as Stone Panda. Researchers at cyber security company Cyfirma have discovered that healthcare companies are being targeted by the Chinese hacking group. According to the information given in the report, the purpose of these cyber attacks by hackers was to break the supply chains of both companies. For this, the groups were looking for loopholes involved in IT infrastructure and supply chain software.

Cyfirma Chief Executive Kumar Ritesh told Reuters that APT10 is continuously carrying out cyber attacks on SII (Serum Institute of India), allowing hackers to influence and overtake supply chains of Indian pharmaceutical companies.

In this case, the Chinese Embassy says that China is committed to cyber safety and opposes any such cyber attack.

As we reported, the US Department of Justice stated in 2018 that APT10 worked closely with the Chinese Ministry of Security. Microsoft said in November that it had detected Russian and North Korean cyber attacks targeting COVID-19 vaccine companies in India, Canada, France, South Korea and the US.

India currently produces 60 percent of the world’s Kovid-19 vaccine. The Indian healthcare company Serum Institute is producing the Covishield vaccine for India as well as the AstraZeneca vaccine for several countries in association with the British pharmaceutical manufacturer. Not only this, SII will also mass produce Novavax vaccine in the coming time.

For the latest tech news, smartphone reviews and exclusive offers on popular mobiles, download the Gadgets 360 Android app and follow us on Google News.

Related news


Leave A Reply

Please enter your comment!
Please enter your name here